A 30% reduction of adverse drug reactions with a pharmacogenomic test.
This EU multicenter cross-over study was designed to have 80% power [...]
New antidepressants study from Norway
The most favourable genotype for SSRI metabolism includes CYP2D6, CYP2C19 and [...]
What can pharmacogenomic do for you?
A short and fine explanation of what pharmacogenomics can do for [...]
The use of PGx in Nursing Homes
Four Nursing Homes in Ontario. Measurements Potential drug therapy problems (DTPs) [...]
Approaches and hurdles of implementing PGx in psychiatric clinic
Despite the many hurdles, PGx testing has great promise to optimize [...]
Time course for benefits and risk with dual antiplatelet therapy
Question What is the time course for benefit and risk with dual [...]
PGx-tests improves care and reduces healthcare costs
Study among cardiovascular patients confirms that PGx panel testing yields more [...]
Pharmacogenomic tests can improve the medical treatment in Psychiatry
A newly Danish study within Psyciatry shows a significant improvement of medical [...]
Data from IPSYC study shows the relevance of PGx testing in psychiatry
Aarhus University Hospital Psychiatry, Aarhus, Denmark, shows in a real-world pharmacogenetic frequency [...]
Personal Medicine Test Succesfully Over The Counter at Danish Pharmacies
Danish article:: https://issuu.com/farmaci/docs/hele-bladet-farmaci-nr-02-2021 A genotype analysis of a persons pharmacogenes help selecting [...]